ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 64 filers reported holding ENZO BIOCHEM INC in Q1 2014. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $224,000 | +58.9% | 20,266 | +20.6% | 0.01% | +50.0% |
| Q1 2017 | $141,000 | +67.9% | 16,800 | +1.4% | 0.00% | +100.0% |
| Q3 2016 | $84,000 | +61.5% | 16,562 | +44.1% | 0.00% | +100.0% |
| Q4 2015 | $52,000 | +73.3% | 11,492 | +14.8% | 0.00% | 0.0% |
| Q2 2015 | $30,000 | -74.4% | 10,013 | -74.7% | 0.00% | -50.0% |
| Q1 2015 | $117,000 | -81.3% | 39,519 | -66.8% | 0.00% | -80.0% |
| Q2 2014 | $625,000 | +1288.9% | 119,057 | +1008.3% | 0.01% | +900.0% |
| Q1 2014 | $45,000 | +66.7% | 10,742 | +0.3% | 0.00% | – |
| Q3 2013 | $27,000 | – | 10,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBERT FUND ADVISORS, INC. | 5,620,681 | $20,234,000 | 30.10% |
| Evermore Global Advisors, LLC | 4,007,851 | $14,428,000 | 3.48% |
| Fondren Management LP | 355,000 | $1,278,000 | 1.06% |
| CORRADO ADVISORS, LLC | 196,309 | $707,000 | 0.64% |
| MARATHON CAPITAL MANAGEMENT | 193,580 | $697,000 | 0.28% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $344,000 | 0.23% |
| EAM Investors, LLC | 203,962 | $734,000 | 0.19% |
| Ariel Investments | 1,026,313 | $3,695,000 | 0.05% |
| HighVista Strategies LLC | 19,500 | $70,000 | 0.05% |
| Paradigm Financial Partners, LLC | 17,175 | $60,000 | 0.03% |